S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

AKBA Akebia Therapeutics Inc

1.4491

-0.0309 (-2.09%)

27 Jul 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Akebia Therapeutics Charts.

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Akebia Therapeutics Charts.

Akebia Therapeutics Inc News

Form 8-K - Current report
Thursday 11 July 2024 (2 weeks ago) • Edgar (US Regulatory)

Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo® (vadadustat) Tablets
Thursday 11 July 2024 (2 weeks ago) • PR Newswire (US)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 2 July 2024 (4 weeks ago) • PR Newswire (US)

Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
Thursday 27 June 2024 (4 weeks ago) • PR Newswire (US)

Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer
Monday 24 June 2024 (1 month ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 11 June 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 11 June 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 11 June 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 11 June 2024 (2 months ago) • Edgar (US Regulatory)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 4 June 2024 (2 months ago) • PR Newswire (US)

Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference
Thursday 23 May 2024 (2 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 15 May 2024 (2 months ago) • Edgar (US Regulatory)

More Akebia Therapeutics Inc News Articles

Resource Mining

Atlantic Coastal Acquisi...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions